ExSAR Corporation is a clinical developmental stage company dedicated to identifying, developing and commercializing small-molecule therapeutics for protein misfolding diseases. Protein misfolding is a prominent feature of a diverse number of diseases, examples of which include Tay-Sachs, Gaucher, Alzheimer's and Parkinson's. ExSAR utilizes their platform technology to screen lead compounds for their ability to prevent protein misfolding and restore protein function.